You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
九強生物(300406.SZ):“新冠病毒抗體檢測試劑盒(膠乳免疫比濁法)”產品獲得CE認證
格隆匯 08-13 19:41

格隆匯 8 月 13日丨九強生物(300406.SZ)公告,公司的新型冠狀病毒抗體檢測試劑盒(膠乳免疫比濁法)產品於近日取得歐盟CE准入資格。

新型冠狀病毒抗體檢測試劑盒(膠乳免疫比濁法)獲得歐盟CE的准入資格,表明該產品符合歐盟相關要求,具備歐盟市場的准入條件,有利於滿足國際市場客户多樣化的臨牀需求,進一步增強公司產品的綜合競爭力,在全球範圍內助力新型冠狀病毒感染的肺炎疫情防控工作。上述產品實際銷售情況取決於新型冠狀病毒感染的肺炎疫情防控涉及的檢測需求,公司目前尚無法預測其對公司未來業績的影響,敬請投資者注意投資風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account